PA
AZZ icon

PharVision Advisers’s AZZ Inc AZZ Stock Holding History

PharVision Advisers’s Portfolio AZZ Stock Details AZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,204
Closed -$241K – 704
2025
Q3 		$241K Buy
+2,204
New +$245K 0.14% 359
2025
Q1 		– Sell
-3,620
Closed -$297K – 291
2024
Q4 		$297K Buy
+3,620
New +$306K 0.25% 161

Other funds holding AZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PharVision Advisers's AZZ Position: Q4 2025 in Review

PharVision Advisers sold out of AZZ Inc (AZZ) in Q4 2025, closing a stake of 2,204 shares — an estimated $241K sold.

PharVision Advisers first reported a position in AZZ in Q4 2024 and held it in 2 quarters. The position peaked at $297K in Q4 2024. 316 funds tracked by Wall St. Rank hold AZZ as of Q4 2025.

  • PharVision Advisers reported no remaining AZZ Inc position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 2,204 AZZ Inc shares in Q4 2025, an estimated $241K.
  • PharVision Advisers first reported a position in AZZ Inc in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's AZZ Inc position peaked at $297K in Q4 2024.
  • 316 funds tracked by Wall St. Rank held AZZ Inc as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.